Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 162

1.

Omitting radiotherapy in women ≥ 65 years with low-risk early breast cancer after breast-conserving surgery and adjuvant endocrine therapy is safe.

Wickberg Å, Liljegren G, Killander F, Lindman H, Bjöhle J, Carlberg M, Blomqvist C, Ahlgren J, Villman K.

Eur J Surg Oncol. 2018 Jul;44(7):951-956. doi: 10.1016/j.ejso.2018.04.002. Epub 2018 Apr 13.

PMID:
29709338
2.

A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).

Lindman H, Andersson M, Ahlgren J, Balslev E, Sverrisdottir A, Holmberg SB, Bengtsson NO, Jacobsen EH, Jensen AB, Hansen J, Tuxen MK, Malmberg L, Villman K, Anderson H, Ejlertsen B, Bergh J, Blomqvist C; Swedish Breast Cancer Group (SweBCG), the Danish Breast Cancer Group (DBCG) and the Scandinavian Breast Cancer Group (SBG).

Eur J Cancer. 2018 May;94:79-86. doi: 10.1016/j.ejca.2018.02.016. Epub 2018 Mar 20.

PMID:
29547834
3.

Behavioural characterization of C57BL/6N and BALB/c female mice in social home cage - Effect of mixed housing in complex environment.

Heinla I, Åhlgren J, Vasar E, Voikar V.

Physiol Behav. 2018 May 1;188:32-41. doi: 10.1016/j.physbeh.2018.01.024. Epub 2018 Jan 31.

4.

Behaviour of freshwater snails (Radix balthica) exposed to the pharmaceutical sertraline under simulated predation risk.

Hedgespeth ML, Karasek T, Ahlgren J, Berglund O, Brönmark C.

Ecotoxicology. 2018 Mar;27(2):144-153. doi: 10.1007/s10646-017-1880-6. Epub 2018 Jan 18.

5.

Feasibility of a self-help web-based intervention targeting young cancer patients with sexual problems and fertility distress.

Wiklander M, Strandquist J, Obol CM, Eriksson LE, Winterling J, Rodriguez-Wallberg KA, Sjögren Fugl-Meyer K, Ahlgren J, Ljungman P, Lampic C, Wettergren L.

Support Care Cancer. 2017 Dec;25(12):3675-3682. doi: 10.1007/s00520-017-3793-6. Epub 2017 Jul 18.

6.

Survival and axillary recurrence following sentinel node-positive breast cancer without completion axillary lymph node dissection: the randomized controlled SENOMAC trial.

de Boniface J, Frisell J, Andersson Y, Bergkvist L, Ahlgren J, Rydén L, Olofsson Bagge R, Sund M, Johansson H, Lundstedt D; SENOMAC Trialists’ Group.

BMC Cancer. 2017 May 26;17(1):379. doi: 10.1186/s12885-017-3361-y.

7.

Oncologists and hematologists' perceptions of fertility-related communication - a nationwide survey.

Micaux Obol C, Armuand GM, Rodriguez-Wallberg KA, Ahlgren J, Ljungman P, Wettergren L, Lampic C.

Acta Oncol. 2017 Aug;56(8):1103-1110. doi: 10.1080/0284186X.2017.1310394. Epub 2017 Apr 5.

PMID:
28379723
8.

Adjuvant Capecitabine in Combination With Docetaxel, Epirubicin, and Cyclophosphamide for Early Breast Cancer: The Randomized Clinical FinXX Trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Lahdenperä O, Kosonen S, Villman K, Nyandoto P, Nilsson G, Poikonen-Saksela P, Kataja V, Junnila J, Bono P, Lindman H.

JAMA Oncol. 2017 Jun 1;3(6):793-800. doi: 10.1001/jamaoncol.2016.6120.

9.

A validation of DCIS registration in a population-based breast cancer quality register and a study of treatment and prognosis for DCIS during 20 years.

Wadsten C, Heyman H, Holmqvist M, Ahlgren J, Lambe M, Sund M, Wärnberg F.

Acta Oncol. 2016 Nov;55(11):1338-1343. Epub 2016 Aug 22.

PMID:
27548561
10.

Effect of selective serotonin reuptake inhibitors use on endocrine therapy adherence and breast cancer mortality: a population-based study.

Valachis A, Garmo H, Weinman J, Fredriksson I, Ahlgren J, Sund M, Holmberg L.

Breast Cancer Res Treat. 2016 Sep;159(2):293-303. doi: 10.1007/s10549-016-3928-3. Epub 2016 Aug 5.

11.

Heritability of hypothyroidism in the Finnish Hovawart population.

Åhlgren J, Uimari P.

Acta Vet Scand. 2016 Jun 7;58(1):39. doi: 10.1186/s13028-016-0221-8.

12.

Aromatase inhibitors alone or sequentially combined with tamoxifen in postmenopausal early breast cancer compared with tamoxifen or placebo - Meta-analyses on efficacy and adverse events based on randomized clinical trials.

Rydén L, Heibert Arnlind M, Vitols S, Höistad M, Ahlgren J.

Breast. 2016 Apr;26:106-14. doi: 10.1016/j.breast.2016.01.006. Epub 2016 Feb 18. Review.

PMID:
27017249
13.

Individual boldness is linked to protective shell shape in aquatic snails.

Ahlgren J, Chapman BB, Nilsson PA, Brönmark C.

Biol Lett. 2015 Apr;11(4):20150029. doi: 10.1098/rsbl.2015.0029.

14.

A stepped care stress management intervention on cancer-related traumatic stress symptoms among breast cancer patients—a randomized study in group vs. individual setting.

Rissanen R, Nordin K, Ahlgren J, Arving C.

Psychooncology. 2015 Sep;24(9):1028-35. doi: 10.1002/pon.3763. Epub 2015 Jan 28.

PMID:
25631707
15.

Sickness absence and disability pension following breast cancer - A population-based matched cohort study.

Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M, Berglund A, Johansson B.

Breast. 2014 Dec;23(6):844-51. doi: 10.1016/j.breast.2014.09.007. Epub 2014 Oct 11.

PMID:
25305791
16.

O-MAX chemotherapy: high activity in metastatic esophagogastric adenocarcinoma and possible relation to subclinical hemolysis.

Ahlgren J, Patel N, Simmens S, Akin E, Bishop C, Kirkel D, Siegel P, Schuck S, Guebre-Xabiher H, Siegel R.

Oncology. 2014;87(6):371-80. doi: 10.1159/000366425. Epub 2014 Sep 13.

PMID:
25227924
17.

Group versus individual stress management intervention in breast cancer patients for fatigue and emotional reactivity: a randomised intervention study.

Rissanen R, Arving C, Ahlgren J, Nordin K.

Acta Oncol. 2014 Sep;53(9):1221-9. doi: 10.3109/0284186X.2014.923935. Epub 2014 Jul 9.

PMID:
25007225
18.

Birth size in the most recent pregnancy and maternal mortality in premenopausal breast cancer by tumor characteristics.

Hajiebrahimi M, Cnattingius S, Lambe M, Hsieh CC, Ahlgren J, Adolfsson J, Bahmanyar S.

Breast Cancer Res Treat. 2014 Jun;145(2):471-80. doi: 10.1007/s10549-014-2956-0. Epub 2014 Apr 18.

PMID:
24744092
19.

Cognitive processing in relation to psychological distress in women with breast cancer: a theoretical approach.

Rissanen R, Arving C, Ahlgren J, Cernvall M, Nordin K.

Psychooncology. 2014 Feb;23(2):222-8. doi: 10.1002/pon.3392. Epub 2013 Sep 16.

PMID:
24105774
20.

Camouflaged or tanned: plasticity in freshwater snail pigmentation.

Ahlgren J, Yang X, Hansson LA, Brönmark C.

Biol Lett. 2013 Oct 23;9(5):20130464.

21.

Outcome of patients with HER2-positive breast cancer treated with or without adjuvant trastuzumab in the Finland Capecitabine Trial (FinXX).

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Saarni O, Helle L, Villman K, Nyandoto P, Nilsson G, Leinonen M, Kataja V, Bono P, Lindman H.

Acta Oncol. 2014 Feb;53(2):186-94. doi: 10.3109/0284186X.2013.820840. Epub 2013 Aug 19.

22.

Changes in health-related quality of life by occupational status among women diagnosed with breast cancer--a population-based cohort study.

Lundh MH, Lampic C, Nordin K, Ahlgren J, Bergkvist L, Lambe M, Berglund A, Johansson B.

Psychooncology. 2013 Oct;22(10):2321-31. doi: 10.1002/pon.3285. Epub 2013 Apr 14.

PMID:
23585294
23.

Do we know enough? A scientific and ethical analysis of the basis for genetic-based personalized nutrition.

Görman U, Mathers JC, Grimaldi KA, Ahlgren J, Nordström K.

Genes Nutr. 2013 Jul;8(4):373-81. doi: 10.1007/s12263-013-0338-6. Epub 2013 Mar 8.

24.

Consumers on the Internet: ethical and legal aspects of commercialization of personalized nutrition.

Ahlgren J, Nordgren A, Perrudin M, Ronteltap A, Savigny J, van Trijp H, Nordström K, Görman U.

Genes Nutr. 2013 Jul;8(4):349-55. doi: 10.1007/s12263-013-0331-0. Epub 2013 Mar 8.

25.

Effects of voluntary wheel running on the kidney at baseline and after ischaemia-reperfusion-induced acute kidney injury: a strain difference comparison.

Moningka NC, Cunningham MW Jr, Sterling M, West CA, Verlander JW, Croker BP, Ahlgren J, Hayward L, Baylis C.

J Physiol. 2013 Mar 1;591(5):1313-24. doi: 10.1113/jphysiol.2012.244327. Epub 2012 Dec 24.

26.

Spaceflight reduces vasoconstrictor responsiveness of skeletal muscle resistance arteries in mice.

Stabley JN, Dominguez JM 2nd, Dominguez CE, Mora Solis FR, Ahlgren J, Behnke BJ, Muller-Delp JM, Delp MD.

J Appl Physiol (1985). 2012 Nov;113(9):1439-45. doi: 10.1152/japplphysiol.00772.2012. Epub 2012 Sep 13.

27.

Impact of comorbidity on management and mortality in women diagnosed with breast cancer.

Berglund A, Wigertz A, Adolfsson J, Ahlgren J, Fornander T, Wärnberg F, Lambe M.

Breast Cancer Res Treat. 2012 Aug;135(1):281-9. doi: 10.1007/s10549-012-2176-4. Epub 2012 Jul 26.

PMID:
22829398
28.

Change in working time in a population-based cohort of patients with breast cancer.

Høyer M, Nordin K, Ahlgren J, Bergkvist L, Lambe M, Johansson B, Lampic C.

J Clin Oncol. 2012 Aug 10;30(23):2853-60. doi: 10.1200/JCO.2011.41.4375. Epub 2012 Jul 9.

PMID:
22778312
29.

Sex differences in fertility-related information received by young adult cancer survivors.

Armuand GM, Rodriguez-Wallberg KA, Wettergren L, Ahlgren J, Enblad G, Höglund M, Lampic C.

J Clin Oncol. 2012 Jun 10;30(17):2147-53. doi: 10.1200/JCO.2011.40.6470. Epub 2012 May 14.

PMID:
22585695
30.

Design of the study: how can health care help female breast cancer patients reduce their stress symptoms? A randomized intervention study with stepped-care.

Nordin K, Rissanen R, Ahlgren J, Burell G, Fjällskog ML, Börjesson S, Arving C.

BMC Cancer. 2012 May 4;12:167. doi: 10.1186/1471-2407-12-167.

31.

Diagenesis of settling seston: identity and transformations of organic phosphorus.

Reitzel K, Ahlgren J, Rydin E, Egemose S, Turner BL, Hupfer M.

J Environ Monit. 2012 Mar;14(3):1098-106. doi: 10.1039/c2em10883f. Epub 2012 Feb 17.

PMID:
22344567
32.

Costs of inducible defence along a resource gradient.

Brönmark C, Lakowitz T, Nilsson PA, Ahlgren J, Lennartsdotter C, Hollander J.

PLoS One. 2012;7(1):e30467. doi: 10.1371/journal.pone.0030467. Epub 2012 Jan 24.

33.

Adherence and discontinuation of adjuvant hormonal therapy in breast cancer patients: a population-based study.

Wigertz A, Ahlgren J, Holmqvist M, Fornander T, Adolfsson J, Lindman H, Bergkvist L, Lambe M.

Breast Cancer Res Treat. 2012 May;133(1):367-73. doi: 10.1007/s10549-012-1961-4.

PMID:
22286315
34.

Barium as a potential indicator of phosphorus in agricultural runoff.

Ahlgren J, Djodjic F, Wallin M.

J Environ Qual. 2012 Jan-Feb;41(1):208-16. doi: 10.2134/jeq2011.0220.

PMID:
22218189
35.

Adjuvant capecitabine, docetaxel, cyclophosphamide, and epirubicin for early breast cancer: final analysis of the randomized FinXX trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Kokko R, Ahlgren J, Auvinen P, Paija O, Helle L, Villman K, Nyandoto P, Nilsson G, Pajunen M, Asola R, Poikonen P, Leinonen M, Kataja V, Bono P, Lindman H.

J Clin Oncol. 2012 Jan 1;30(1):11-8. doi: 10.1200/JCO.2011.35.4639. Epub 2011 Nov 21.

PMID:
22105826
36.

Role of lateral parabrachial opioid receptors in exercise-induced modulation of the hypotensive hemorrhage response in conscious male rats.

Ahlgren JK, Hayward LF.

Behav Brain Res. 2012 Jan 15;226(2):404-10. doi: 10.1016/j.bbr.2011.09.036. Epub 2011 Oct 1.

37.

Health-related quality of life among women with breast cancer - a population-based study.

Høyer M, Johansson B, Nordin K, Bergkvist L, Ahlgren J, Lidin-Lindqvist A, Lambe M, Lampic C.

Acta Oncol. 2011 Oct;50(7):1015-26. doi: 10.3109/0284186X.2011.577446. Epub 2011 May 23.

PMID:
21604959
38.

Breast cancer, sickness absence, income and marital status. A study on life situation 1 year prior diagnosis compared to 3 and 5 years after diagnosis.

Eaker S, Wigertz A, Lambert PC, Bergkvist L, Ahlgren J, Lambe M; Uppsala/Örebro Breast Cancer Group.

PLoS One. 2011 Mar 30;6(3):e18040. doi: 10.1371/journal.pone.0018040.

39.

Dose-tailoring of FEC adjuvant chemotherapy based on leukopenia is feasible and well tolerated. Toxicity and dose intensity in the Scandinavian Breast Group phase 3 adjuvant Trial SBG 2000-1.

Edlund P, Ahlgren J, Bjerre K, Andersson M, Bergh J, Mouridsen H, Holmberg SB, Bengtsson NO, Jakobsen E, Møller S, Lindman H, Blomqvist C.

Acta Oncol. 2011 Apr;50(3):329-37. doi: 10.3109/0284186X.2011.554435. Epub 2011 Feb 8.

PMID:
21299448
40.

Daily voluntary exercise alters the cardiovascular response to hemorrhage in conscious male rats.

Ahlgren JK, Hayward LF.

Auton Neurosci. 2011 Feb 24;160(1-2):42-52. doi: 10.1016/j.autneu.2010.11.010. Epub 2011 Jan 6.

41.

Release of organic P forms from lake sediments.

Ahlgren J, Reitzel K, De Brabandere H, Gogoll A, Rydin E.

Water Res. 2011 Jan;45(2):565-72. doi: 10.1016/j.watres.2010.09.020. Epub 2010 Oct 12.

PMID:
20947118
42.

Adjuvant capecitabine in combination with docetaxel and cyclophosphamide plus epirubicin for breast cancer: an open-label, randomised controlled trial.

Joensuu H, Kellokumpu-Lehtinen PL, Huovinen R, Jukkola-Vuorinen A, Tanner M, Asola R, Kokko R, Ahlgren J, Auvinen P, Hemminki A, Paija O, Helle L, Nuortio L, Villman K, Nilsson G, Lahtela SL, Lehtiö K, Pajunen M, Poikonen P, Nyandoto P, Kataja V, Bono P, Leinonen M, Lindman H; FinXX Study Investigators.

Lancet Oncol. 2009 Dec;10(12):1145-51. doi: 10.1016/S1470-2045(09)70307-9. Epub 2009 Nov 10.

PMID:
19906561
43.

Reductions in use of hormone replacement therapy: effects on Swedish breast cancer incidence trends only seen after several years.

Lambe M, Wigertz A, Holmqvist M, Adolfsson J, Bardage C, Fornander T, Karlsson P, Odlind V, Persson I, Ahlgren J, Bergkvist L.

Breast Cancer Res Treat. 2010 Jun;121(3):679-83. doi: 10.1007/s10549-009-0615-7. Epub 2009 Nov 6.

PMID:
19894110
44.

Gemcitabine and capecitabine in combination for advanced anthracycline and taxane pre-treated breast cancer patients: A phase II study.

Malmström A, Hansen J, Malmberg L, Carlsson L, Svensson JH, Ahlgren J, Ahlin C, Jansson T, Westberg R.

Acta Oncol. 2010;49(1):35-41. doi: 10.3109/02841860903268031.

PMID:
19839920
45.

The risk of amenorrhoea after adjuvant chemotherapy for early stage breast cancer is related to inter-individual variations in chemotherapy-induced leukocyte nadir in young patients: data from the randomised SBG 2000-1 study.

Rosendahl M, Ahlgren J, Andersen J, Bergh J, Blomquist C, Lidbrink E, Lindman H, Mouridsen H, Bjerre K, Andersson M.

Eur J Cancer. 2009 Dec;45(18):3198-204. doi: 10.1016/j.ejca.2009.09.019. Epub 2009 Oct 7.

PMID:
19818599
46.

Modulation of heart rate variability during severe hemorrhage at different rates in conscious rats.

Porter K, Ahlgren J, Stanley J, Hayward LF.

Auton Neurosci. 2009 Oct 5;150(1-2):53-61. doi: 10.1016/j.autneu.2009.04.009. Epub 2009 May 23.

47.

Social differences in breast cancer survival in relation to patient management within a National Health Care System (Sweden).

Eaker S, Halmin M, Bellocco R, Bergkvist L, Ahlgren J, Holmberg L, Lambe M; Uppsala/Orebro Breast Cancer Group.

Int J Cancer. 2009 Jan 1;124(1):180-7. doi: 10.1002/ijc.23875.

48.

Phorbol 12-myristate 13-acetate inhibits FRO anaplastic human thyroid cancer cell proliferation by inducing cell cycle arrest in G1/S phase: evidence for an effect mediated by PKCdelta.

Afrasiabi E, Ahlgren J, Bergelin N, Törnquist K.

Mol Cell Endocrinol. 2008 Sep 24;292(1-2):26-35. doi: 10.1016/j.mce.2008.04.018. Epub 2008 May 4.

PMID:
18541361
49.

Sediment extraction and clean-up for organic phosphorus analysis by electrospray ionization tandem mass spectrometry.

De Brabandere H, Danielsson R, Sjöberg PJ, Ahlgren J, Rydin E, Waldebäck M.

Talanta. 2008 Feb 15;74(5):1175-83. doi: 10.1016/j.talanta.2007.08.030. Epub 2007 Sep 2.

PMID:
18371767
50.

Sediment phosphorus extractants for phosphorus-31 nuclear magnetic resonance analysis: a quantitative evaluation.

Ahlgren J, De Brabandere H, Reitzel K, Rydin E, Gogoll A, Waldebäck M.

J Environ Qual. 2007 May 7;36(3):892-8. Print 2007 May-Jun.

PMID:
17485721

Supplemental Content

Loading ...
Support Center